These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

224 related items for PubMed ID: 30116997

  • 1. Adjuvant Pharmacotherapies to Insulin for the Treatment of Type 1 Diabetes.
    Tosur M, Redondo MJ, Lyons SK.
    Curr Diab Rep; 2018 Aug 17; 18(10):79. PubMed ID: 30116997
    [Abstract] [Full Text] [Related]

  • 2. Effects of Sodium-Glucose Cotransporter Inhibitor/Glucagon-Like Peptide-1 Receptor Agonist Add-On to Insulin Therapy on Glucose Homeostasis and Body Weight in Patients With Type 1 Diabetes: A Network Meta-Analysis.
    Kim YJ, Hwang SD, Lim S.
    Front Endocrinol (Lausanne); 2020 Aug 17; 11():553. PubMed ID: 32973680
    [Abstract] [Full Text] [Related]

  • 3. Non-insulin pharmacological therapies for treating type 1 diabetes.
    Frandsen CS, Dejgaard TF, Madsbad S, Holst JJ.
    Expert Opin Pharmacother; 2018 Jun 17; 19(9):947-960. PubMed ID: 29991320
    [Abstract] [Full Text] [Related]

  • 4. THE EMERGING ROLE OF ADJUNCTIVE NONINSULIN ANTIHYPERGLYCEMIC THERAPY IN THE MANAGEMENT OF TYPE 1 DIABETES.
    Bode BW, Garg SK.
    Endocr Pract; 2016 Feb 17; 22(2):220-30. PubMed ID: 26484403
    [Abstract] [Full Text] [Related]

  • 5. Complementing insulin therapy to achieve glycemic control.
    Barnett AH.
    Adv Ther; 2013 Jun 17; 30(6):557-76. PubMed ID: 23797471
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. The Effect of Glucagon-Like Peptide-1 Receptor Agonists and Sodium-Glucose Cotransporter-2 Inhibitors in Patients Prescribed Regular U-500 Insulin.
    Meade LT, Mannka ML.
    Ann Pharmacother; 2019 Nov 17; 53(11):1111-1116. PubMed ID: 31215219
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. SGLT inhibition: a possible adjunctive treatment for type 1 diabetes.
    Akturk HK, Rewers A, Garg SK.
    Curr Opin Endocrinol Diabetes Obes; 2018 Aug 17; 25(4):246-250. PubMed ID: 29794497
    [Abstract] [Full Text] [Related]

  • 13. Reducing Type 1 Diabetes Mortality: Role for Adjunctive Therapies?
    Snaith JR, Holmes-Walker DJ, Greenfield JR.
    Trends Endocrinol Metab; 2020 Feb 17; 31(2):150-164. PubMed ID: 31822381
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Adjunctive therapies in type 1 diabetes mellitus.
    Lane K, Freeby M.
    Curr Opin Endocrinol Diabetes Obes; 2021 Feb 01; 28(1):8-13. PubMed ID: 33332928
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. New developments in diabetes management: medications of the 21st century.
    Fonseca VA.
    Clin Ther; 2014 Apr 01; 36(4):477-84. PubMed ID: 24594068
    [Abstract] [Full Text] [Related]

  • 19. Using adjuvant pharmacotherapy in the treatment of type 1 diabetes.
    Sjöholm Å.
    Expert Opin Pharmacother; 2021 Nov 01; 22(16):2143-2148. PubMed ID: 34132620
    [Abstract] [Full Text] [Related]

  • 20. Cardiovascular Effects of Glucose-lowering Therapies for Type 2 Diabetes: New Drugs in Perspective.
    Thompson PL, Davis TME.
    Clin Ther; 2017 May 01; 39(5):1012-1025. PubMed ID: 27863704
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.